Bharat Biotech working on developing dengue vaccine: Officials

Hyderabad, India, Oct 20 (UNB) - BHARAT BIOTECH, one of India's leading vaccine manufacturers, is working on the development of dengue vaccine.
At the same time, the BHARAT BIOTECH authority has announced that the third trial for Chikungunya vaccine is currently at the approval stage.
This information was provided by the Indian vaccine manufacturer in a presentation to the visiting Bangladeshi delegation of journalists at the BHARAT BIOTECH factory in Hyderabad on Thursday.
The authorities at BHARAT BIOTECH said, "We are actively engaged in the development of a dengue vaccine. The dengue virus is highly complicated, as its variants change rapidly, making it challenging to work with."
At the same time, vaccines for mosquito-borne disease Chikungunya, as well as the lumpy skin disease, prevalent among animals, are currently awaiting approval following the completion of the third trial, the vaccine manufacturer said.